Infantile Spasms

20 registered clinical trials studyying Infantile Spasms — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Prevent Infantile Spasms Relapse NCT06819670	University of California, Los Angeles	Phase 2
Recruiting	Artificial Intelligence-based Video Analysis to Detect Infantile Spasms NCT06315829	Johns Hopkins University	—
Withdrawn	Prednisolone Versus Vigabatrin in the First-line Treatment of Infantile Spasms NCT02299115	The Hospital for Sick Children	Phase 3
Completed	Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7) NCT02954887	Jazz Pharmaceuticals	Phase 3
Completed	Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7) NCT02953548	Jazz Pharmaceuticals	Phase 3
Completed	Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Ph NCT02220114	Orphelia Pharma	N/A
Completed	Evaluation of Neuroinflammation in Children With Infantile Spasms NCT02092883	Wayne State University	Phase 4
Completed	Genetic Studies in Patients and Families With Infantile Spasms NCT01723787	University of Colorado, Denver	—
Completed	Addition of Pyridoxine to Prednisolone in Infantile Spasms NCT01828437	Lady Hardinge Medical College	Phase 3
Withdrawn	An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spa NCT01413711	Lundbeck LLC	Phase 4
Withdrawn	Trial of the Modified Atkins Diet in Infantile Spasms Refractory to Hormonal Therapy NCT01549288	Lady Hardinge Medical College	Phase 2 / Phase 3
Completed	Prednisolone in Infantile Spasms- High Dose Versus Usual Dose NCT01575639	Lady Hardinge Medical College	Phase 3
Completed	Molecular Genetics in Infantile Spasms NCT02885389	Hospices Civils de Lyon	—
Completed	Use of the Modified Atkins Diet in Infantile Spasms NCT01006811	All India Institute of Medical Sciences	Phase 2 / Phase 3
Completed	Sabril Patient Registry NCT01073579	Lundbeck LLC	—
Completed	Epilepsy Phenome/Genome Project NCT00552045	University of California, San Francisco	—
Completed	A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms NCT00441896	Marinus Pharmaceuticals	Phase 2
Terminated	Open-label Extension to Protocol 1042-0500 NCT00442104	Marinus Pharmaceuticals	Phase 2
Completed	Metabolic Abnormalities in Children With Epilepsy NCT00001325	National Institute of Neurological Disorders and Stroke (NINDS)	—
Completed	Short-term Ketogenic Diet as Compared With Conventional Long-term Trial in Refractory Infantile Spasms: A Rand NCT00968136	Yonsei University	—